Topical composition

By blending silicon dioxide and polyacrylic acid or its derivatives with petrolatum, the composition addresses shine and adhesion issues, ensuring effective moisturization and skin adhesion without stickiness.

JP2024162159AInactive Publication Date: 2024-11-21ROHTO PHARM CO LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2023077445
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-09
Publication Date
2024-11-21
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing external compositions containing petrolatum cause shine and reduce adhesion to the skin, compromising their emollient and occlusive effects when the petrolatum content is reduced to minimize shine.

Method used

Incorporating silicon dioxide and polyacrylic acid or its derivatives into a composition with petrolatum to enhance adhesion while suppressing shine and stickiness.

Benefits of technology

The combination of silicon dioxide and polyacrylic acid or its derivatives in a petrolatum-based composition maintains emollient effects, reduces shine, and improves skin adhesion, providing a smooth and non-sticky application experience.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024162159000001
    Figure 2024162159000001
Patent Text Reader

Abstract

To provide a vaseline-containing topical composition that reduces skin shine after application and exhibits superior skin adhesion.SOLUTION: A topical composition includes (A) silicon dioxide, (B) polyacrylic acid or a derivative thereof and (C) vaseline. The topical composition further may contain liquid polar oil, liquid nonpolar oil, and / or solid oil other than vaseline. It may be substantially free of water.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a topical composition containing petrolatum. [Background technology]

[0002] Emollients are ingredients that prevent water evaporation from the skin, retain moisture, and soften the skin. In the skin, water diffuses from the body to the stratum corneum, and the intercellular lipids and sebum membrane of the stratum corneum suppress water evaporation, resulting in an emollient effect on the skin. When the intercellular lipids and sebum membrane of the stratum corneum are insufficient, it is effective to apply a topical composition containing an emollient to the skin in order to maintain moisture in the stratum corneum. As the emollient, various oily substances that spread smoothly on the skin surface and have high skin occlusion properties are suitable. Among them, petrolatum is widely used as an emollient because it has been used for many years and its safety has been established, and it is inexpensive. However, when a topical composition containing Vaseline is applied to the skin, the skin becomes shiny, which is unpleasant for many users. Reducing the amount of petrolatum or other oils will reduce shine, but will also reduce adhesion of the topical composition to the skin and will not provide sufficient emollient or occlusive effect. Summary of the Invention [Problem to be solved by the invention]

[0003] The present invention aims to provide a petrolatum-containing external composition which causes less greasiness on the skin after application and has good adhesion to the skin. [Means for solving the problem]

[0004] The present inventors have conducted extensive research to solve the above problems and have found that by blending (A) silicon dioxide and (B) polyacrylic acid or a derivative thereof in addition to (C) petrolatum in a composition for external use, the shine of the skin after application is suppressed and adhesion to the skin is improved. The present invention was completed based on the above findings, and provides a composition for external use comprising (A) silicon dioxide, (B) polyacrylic acid or a derivative thereof, and (C) petrolatum. Effect of the Invention

[0005] The topical composition of the present embodiment suppresses shine after application to the skin even when it contains petrolatum, which only exerts an emollient effect. Silicon dioxide and polyacrylic acid or its derivatives are additives that are usually added to aqueous compositions containing a large amount of water to exert their functions, but the topical composition of the present embodiment combines petrolatum, which is an oily substance, with silicon dioxide and polyacrylic acid or its derivatives, thereby forming a preparation with good adhesion while suppressing skin shine.

[0006] In addition, the external composition of this embodiment contains petrolatum, which is known to be sticky, but still provides a smooth and good feeling of use.As shown in the example section, by incorporating polyacrylic acid or its derivative, the sticky feeling during application and the sticky feeling on the skin after application are suppressed.Since polyacrylic acid or its derivative is a component that is usually used as a thickener, it is expected that the stickiness will increase by incorporating polyacrylic acid or its derivative, but in the external composition of this embodiment, by combining with petrolatum and silicon dioxide, polyacrylic acid or its derivative has the effect of suppressing stickiness. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0007] The present invention will be described in detail below. The topical composition of this embodiment is a composition containing (A) silicon dioxide, (B) polyacrylic acid or a derivative thereof, and (C) petrolatum.

[0008] Component (A) (silicon dioxide) The silicon dioxide may be anhydrous silicic acid, light anhydrous silicic acid, or anhydrous silicic acid hydrate, with light anhydrous silicic acid being preferred. The concentration of silicon dioxide can be 1% by mass or more, 3% by mass or more, or 4% by mass or more based on the total amount of the composition. Within this range, the effect of the present invention can be fully obtained. Furthermore, the concentration of silicon dioxide can be 10% by mass or less, 9% by mass or less, 7.5% by mass or less, or 6% by mass or less based on the total amount of the composition. Within this range, the composition for external use can be prevented from becoming too hard or from coagulating. One or more types of silicon dioxide can be used.

[0009] The average particle size of silicon dioxide can be 1 μm or more, 2 μm or more, or 3 μm or more. Within this range, it is easy to absorb oily components and swell, and the effects of the present invention can be fully obtained. The average particle size of silicon dioxide can be 10 μm or less, 7 μm or less, 5 μm or less, or 4 μm or less. The average particle size is measured by a volume-based calculation method using a laser diffraction particle size distribution measuring device. The device used is SALD-2200 from Shimadzu Corporation.

[0010] Component (B) (polyacrylic acid or its derivative) Polyacrylic acid or its derivatives are polymers formed by polymerizing monomers containing carboxylic acid. Either non-crosslinked or crosslinked polyacrylic acid or its derivatives can be used, but crosslinked polyacrylic acid or its derivatives are preferred. Examples of crosslinked polyacrylic acid include carboxyvinyl polymers. Examples of the derivatives of polyacrylic acid include alkyl acrylate copolymers, alkyl acrylate copolymers, acrylates copolymers, acrylates crosspolymers, alkyl acrylate methacrylate copolymers, and (acrylic acid / alkyl acrylate (C10-30)) copolymers.

[0011] The carboxyl group of the polyacrylic acid or its derivative may be neutralized or not, but it is preferable that the polyacrylic acid or its derivative is not neutralized. If the polyacrylic acid or its derivative is not neutralized, it is likely to absorb oily components such as petrolatum and swell, and the effect of the present invention is more pronounced. Therefore, the external composition of the present embodiment may or may not contain a basic pH adjuster, but it is preferable that it does not contain a basic pH adjuster.Because the composition is mainly composed of oily components, it is preferable that it does not contain a basic pH adjuster.Basic pH adjusters include alkanolamines such as monoethanolamine, diethanolamine, triethanolamine, monoisopropanolamine, diisopropanolamine, triisopropanolamine, and tetrahydroxypropylethylenediamine; inorganic bases such as sodium hydroxide, potassium hydroxide, calcium hydroxide, magnesium hydroxide, and ammonia; and basic amino acids such as glycine and arginine.

[0012] The concentration of polyacrylic acid or its derivatives can be 1% by mass or more, 2% by mass or more, or 3% by mass or more based on the total amount of the composition. Within this range, the formulation has good adhesion while suppressing shine, has good usability, and is excellent in thermal stability. In addition, the concentration of polyacrylic acid or its derivatives can be 7% by mass or less, 6% by mass or less, 4.5% by mass or less, or 4% by mass or less based on the total amount of the composition. Within this range, the composition does not clump during preparation.

[0013] The content ratio of polyacrylic acid or its derivative in the (A) component can be 0.1 parts by mass or more, 0.3 parts by mass or more, or 0.5 parts by mass or more per 1 part by mass of silicon dioxide. Within this range, the formulation has good adhesion while suppressing shine, has a good feel in use, and is excellent in thermal stability. In addition, the content ratio of polyacrylic acid or its derivative in the (A) component can be 2 parts by mass or less, 1 part by mass or less, or 0.75 parts by mass or less per 1 part by mass of silicon dioxide. Within this range, the composition does not clump during preparation.

[0014] (C) Ingredient (Vaseline) Vaseline includes yellow vaseline, white vaseline, etc., depending on the purity. One or more types of vaseline can be used.

[0015] The concentration of Vaseline can be 3% by mass or more, 5% by mass or more, 10% by mass or more, or 20% by mass or more based on the total amount of the composition. Within this range, the emollient effect or occlusive effect is sufficiently obtained, and the adhesion to the skin is good. In addition, the concentration of Vaseline can be 40% by mass or less, 30% by mass or less, 25% by mass or less, or 20% by mass or less based on the total amount of the composition. Within this range, the shine and stickiness of the skin can be suppressed.

[0016] The content ratio of petrolatum in component (A) can be 0.1 parts by mass or more, 0.8 parts by mass or more, or 1 part by mass or more per 1 part by mass of silicon dioxide. Within this range, the emollient effect or occlusive effect is sufficiently obtained, and the adhesion to the skin is good. Furthermore, the content ratio of petrolatum in component (A) can be 5 parts by mass or less, 3 parts by mass or less, or 2 parts by mass or less per 1 part by mass of silicon dioxide. Within this range, the shine and stickiness of the skin can be suppressed.

[0017] The content ratio of petrolatum to component (B) can be 0.1 parts by mass or more, 1 part by mass or more, or 2 parts by mass or more per part by mass of polyacrylic acid or its derivative. Within this range, the emollient effect or occlusive effect is sufficiently obtained, and the adhesion to the skin is good. Furthermore, the content ratio of petrolatum to component (B) can be 30 parts by mass or less, 20 parts by mass or less, or 5 parts by mass or less per part by mass of polyacrylic acid or its derivative. Within this range, the shine and stickiness of the skin can be suppressed.

[0018] (D) Ingredient (solid oil other than petrolatum) The topical composition of the present embodiment may contain a solid oil other than Vaseline. In the present invention, a "solid oil" is an oily component having a melting point of 25° C. or higher, or a semi-solid oily component that has no fluidity at 25° C. The oil may be either a polar oil or a non-polar oil. Examples of solid oils other than Vaseline include solid hydrocarbons such as gelled hydrocarbons (such as Plastibase), ozokerite (including ceresin wax which is refined from ozokerite), microcrystalline wax, paraffin, polyethylene powder, and polybutene; oils and fats such as shea butter, carnauba wax, cocoa butter, candelilla wax, lanolin, beeswax, spermaceti, hardened oil, hydrogenated palm oil, and hydrogenated jojoba oil; higher alcohols such as cetanol, cetostearyl alcohol, stearyl alcohol, and behenyl alcohol; and sterols such as cholesterol, phytosterol, and phytosteryl hydroxystearate. The solid oil other than vaseline may be used alone or in combination with two or more other solid oils having different melting points, which is particularly preferred since it improves the thermal stability.

[0019] The concentration of the solid oil other than Vaseline can be 5% by mass or more, 10% by mass or more, or 12% by mass or more based on the total amount of the composition. Within this range, the formulation has good adhesion while suppressing shine, has good usability, and is excellent in heat stability. In addition, the concentration of the solid oil other than Vaseline can be 30% by mass or less, 25% by mass or less, or 15% by mass or less based on the total amount of the composition. Within this range, syneresis due to the concentration of the solid oil being too low or too high can be avoided.

[0020] The content ratio of the solid oil other than petrolatum in the component (C) can be 0.2 parts by mass or more, or 0.6 parts by mass or more, per 1 part by mass of petrolatum. Within this range, the formulation has good adhesion while suppressing shine, has a good feel when used, and has excellent heat stability. In addition, the content ratio of the solid oil other than petrolatum in the component (C) can be 1.5 parts by mass or less, or 0.9 parts by mass or less, per 1 part by mass of petrolatum. Within the above range, syneresis due to the concentration of the solid oil being too low or too high can be avoided.

[0021] The content ratio of the solid oil other than petrolatum in the (B) component can be 0.1 parts by mass or more, 1 part by mass or more, or 2 parts by mass or more per 1 part by mass of polyacrylic acid or its derivative. Within this range, the formulation has good adhesion while suppressing shine, has a good feel in use, and is excellent in thermal stability. In addition, the content ratio of the solid oil other than petrolatum in the (B) component can be 30 parts by mass or less, 10 parts by mass or less, or 5 parts by mass or less per 1 part by mass of polyacrylic acid or its derivative. Within this range, the formulation can be prevented from becoming too hard due to the concentration of the solid oil becoming too high.

[0022] Component (E) (liquid polar oil) The topical composition of the present embodiment may contain a polar liquid oil. In the present invention, the "liquid polar oil" refers to an oily component that has a polar structure, such as an ester bond, an ether bond, a carbonyl group, or a hydroxyl group, and is liquid or fluid at 25°C. Examples of liquid polar oils include ester oils having an ester bond in the molecule, ether oils having an ether bond, and higher alcohols having a hydroxy group.

[0023] Examples of the liquid ester oil include liquid monoester oil, liquid diester oil, liquid triester oil (including liquid triglyceride oil), and liquid tetraester oil. Examples of liquid monoester oils include isopropyl myristate, isostearyl myristate, octyldodecyl myristate, isopropyl palmitate, isooctyl palmitate, isononyl isononanoate, isotridecyl isononanoate, cetyl octanoate (cetyl 2-ethylhexanoate), 2-hexyldecyl isostearate, and isostearyl isostearate. Examples of liquid diester oils include neopentyl glycol dicaprate, glyceryl diisostearate, diisopropyl adipate, diisobutyl adipate, diethyl sebacate, diisopropyl sebacate, di-2-ethylhexyl sebacate, diethoxyethyl succinate, diethylhexyl succinate, and diisostearyl malate. Liquid triester oils include avocado oil, macadamia nut oil, camellia oil, evening primrose oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, jojoba oil, rapeseed oil, castor oil, cottonseed oil, soybean oil, rice bran oil, rice germ oil, wheat germ oil, peanut oil, sunflower oil, almond oil, coconut oil, orange oil, palm oil, meadowfoam oil, sage oil, mink oil, rosemary oil, rosehip oil, Orange roughy oil, medium chain triglycerides, glyceryl tri-2-ethylhexanoate, glyceryl triisooctanoate, trimethylolpropane triisostearate, glyceryl triisostearate, glyceryl triisopalmitate, glyceryl tricaprylate, caprylic / capric triglyceride, caprylic / capric / myristic / stearic triglyceride. An example of the liquid tetraester oil is pentaerythrityl tetra-2-ethylhexanoate.

[0024] Examples of liquid ether oils include dicaprylyl ether; glycol ethers such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monopropyl ether, diethylene glycol monobutyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, dipropylene glycol monoethyl ether, and dipropylene glycol monopropyl ether.

[0025] Examples of liquid higher alcohols include octyldodecanol, oleyl alcohol, and isostearyl alcohol.

[0026] Among these, medium-chain fatty acid triglycerides, isopropyl myristate, octyldodecanol, and diethyl sebacate are preferred, and diethyl sebacate is more preferred. The liquid polar oils may be used alone or in combination of two or more.

[0027] The concentration of the liquid polar oil can be 20% by mass or more, 30% by mass or more, or 38% by mass or more based on the total amount of the composition. Within this range, the formulation has good adhesion while suppressing shine, has a good feel when used, and is well absorbed into the skin. The concentration of the liquid polar oil can be 55% by mass or less, 50% by mass or less, or 48% by mass or less based on the total amount of the composition. Within this range, syneresis due to instability of the composition can be avoided.

[0028] The content ratio of the liquid polar oil relative to the (A) component can be 1 part by mass or more, or 6 parts by mass or more, relative to 1 part by mass of silicon dioxide. Within this range, the formulation has good adhesion while suppressing shine, has a good feel when used, and is well absorbed into the skin. In addition, the content ratio of the liquid polar oil relative to the (A) component can be 15 parts by mass or less, or 8 parts by mass or less, relative to the total amount of the composition. Within this range, syneresis due to instability of the composition can be avoided.

[0029] The content ratio of the liquid polar oil to the component (C) can be 0.5 parts by mass or more, 1 part by mass or more, or 2 parts by mass or more per 1 part by mass of solid oil other than petrolatum. Within this range, the formulation has good adhesion while suppressing shine, has a good feel when used, and is well absorbed into the skin. In addition, the content ratio of the liquid polar oil to the component (C) can be 8 parts by mass or less, 5 parts by mass or less, or 4 parts by mass or less with respect to the total amount of the composition. Within this range, syneresis due to instability of the composition can be avoided.

[0030] Component (F) (liquid non-polar oil) The topical composition of the present embodiment may contain a non-polar liquid oil. In the present invention, the "liquid non-polar oil" is an oily component that does not have a polar structure such as an ester bond, an ether bond, a carbonyl group, or a hydroxyl group, and is liquid at 25°C. Examples of liquid non-polar oils include liquid hydrocarbons such as α-olefin oligomers, liquid paraffin, light liquid paraffin, liquid isoparaffin, light liquid isoparaffin, heavy liquid paraffin, heavy liquid isoparaffin, and squalane; and silicone oils such as methylpolysiloxane, crosslinked methylpolysiloxane, dimethylpolysiloxane, methylphenylpolysiloxane, highly polymerized methylpolysiloxane, cyclopentasiloxane, and decamethylpentasiloxane. Among these, liquid hydrocarbons are preferred, and liquid paraffin is more preferred. One or more types of liquid non-polar oils can be used.

[0031] The concentration of the liquid non-polar oil may be 30% by mass or more, 15% by mass or more, or 19% by mass or more, based on the total amount of the composition. It may also be 40% by mass or less, 30% by mass or less, or 25% by mass or less. Within this range, the effects of the present invention can be sufficiently obtained.

[0032] The content ratio of the liquid non-polar oil in the component (B) can be 2 parts by mass or more, 4 parts by mass or more, or 4.5 parts by mass or more per 1 part by mass of polyacrylic acid or its derivative. It can also be 7 parts by mass or less, 6 parts by mass or less, or 5 parts by mass or less. Within this range, the effects of the present invention can be sufficiently obtained.

[0033] The content ratio of the liquid non-polar oil to the liquid polar oil can be 0.05 parts by mass or more, or 0.2 parts by mass or more, per 1 part by mass of the liquid polar oil. It can also be 1 part by mass or less, or 0.6 parts by mass or less. Within this range, the effects of the present invention can be sufficiently obtained.

[0034] In this embodiment, the "oil component" including components (C), (D), (E), and (F) refers to a compound having an IOB value of 0.6 or less in an organic conceptual diagram.

[0035] water The topical composition of this embodiment may contain water. In particular, when a water-soluble active ingredient is blended, water may be blended to dissolve the active ingredient. The concentration of water may be 10% by mass or less, 5% by mass or less, 3% by mass or less, 1% by mass or less, 0.5% by mass or less, or 0.1% by mass or less, based on the total amount of the topical composition. The topical composition may be substantially free of water, and may not contain water at all. Silicon dioxide, polyacrylic acid or its derivatives are usually blended in compositions containing a large amount of water, and are dispersed in such compositions to exert their effects.In contrast, in the present invention, silicon dioxide, polyacrylic acid or its derivatives are considered to exert the effects unique to the present invention, such as suppression of shine, improvement of adhesion, and reduction of stickiness, in a state of swelling by absorbing oils including Vaseline.Therefore, when the content of water is small, the effects of the present invention are more pronounced.

[0036] The topical composition of the present embodiment may contain one or more additives within a range that does not impair the effects of the present invention. Examples of the additives include an aqueous base, an antioxidant, a surfactant, a texture improver, a chelating agent, a preservative or antiseptic, a colorant, and a fragrance.

[0037] The aqueous base includes lower alcohols and polyhydric alcohols. Examples of the lower alcohol include ethanol and isopropanol. Examples of polyhydric alcohols include low molecular weight compounds (non-polymers) having two or more hydroxy groups, such as glycerin, diglycerin, propylene glycol, dipropylene glycol, 1,4-butanediol, ethylene glycol, diethylene glycol, isoprene glycol, 1,3-butylene glycol, 1,3-propanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, decanediol, sorbitol, xylitol, erythritol, and mannitol. The topical composition of this embodiment may contain an aqueous base to dissolve the active ingredient that is not dissolved in the oily ingredient, but in order to make the effect of the present invention more prominent, it is preferable that the content of the aqueous base is small.The concentration of the aqueous base can be 15% by mass or less, 10% by mass or less, 8% by mass or less, 5% by mass or less, 3% by mass or less, or 1% by mass or less based on the total amount of the composition.The topical composition of this embodiment may not contain an aqueous base.

[0038] Examples of antioxidants include dibutylhydroxytoluene, butylhydroxyanisole, sorbic acid, sodium sulfite, ascorbic acid, ascorbic acid derivatives, tocopherol, tocopherol derivatives (tocopherol acetate, etc.), tocotrienol, hydrogen sulfite, sodium hyposulfite, erythorbic acid, sodium erythorbate, and L-cysteine ​​hydrochloride.

[0039] Examples of the surfactant include a nonionic surfactant, a cationic surfactant, an anionic surfactant, and an amphoteric surfactant. Examples of nonionic surfactants include sorbitan fatty acid esters such as sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, diglycerol sorbitan penta-2-ethylhexyl acid, and diglycerol sorbitan tetra-2-ethylhexyl acid; propylene glycol fatty acid esters such as propylene glycol monostearate; polyoxyethylene hydrogenated castor oil 40 (HCO-40), polyoxyethylene hydrogenated castor oil 50, and the like. (HCO-50), polyoxyethylene hydrogenated castor oil 60 (HCO-60), polyoxyethylene hydrogenated castor oil 80 and other hydrogenated castor oil derivatives; polyoxyethylene (20) sorbitan monolaurate (polysorbate 20), polyoxyethylene (20) sorbitan monostearate (polysorbate 60), polyoxyethylene (20) sorbitan monooleate (polysorbate 80), polyoxyethylene (20) sorbitan isostearate and other polyoxyethylene sorbitan fatty acid esters; Polyoxyethylene monococonut oil fatty acid glyceryl; glycerin alkyl ethers such as glycerin monooleyl ether and glycerin monosteric ether; glycerin fatty acid esters such as glyceryl oleate, glyceryl myristate, glyceryl stearate, and glyceryl isostearate; polyglyceryl-2 oleate, polyglyceryl-2 stearate, polyglyceryl-10 oleate, polyglyceryl-10 stearate, polyglyceryl-10 laurate, and polyglyceryl distearate. polyglycerin fatty acid esters such as polyglyceryl-10 trioleate, polyglyceryl-10 pentaoleate, and polyglyceryl-10 pentastearate; polyoxyethylene fatty acid esters such as polyoxyl 40 stearate and polyoxyl 55 stearate; alkyl glucosides; polyoxyalkylene alkyl ethers such as polyoxyethylene lauryl ether, polyoxyethylene cetyl ether, polyoxyethylene stearyl ether, and polyoxyethylene behenyl ether;Examples of such surfactants include polyoxyethylene-polyoxypropylene block copolymers such as polyoxyethylene (196) polyoxypropylene (67) glycol, polyoxyethylene (200) polyoxypropylene (70) glycol, polyoxyethylene (20) polyoxypropylene (4) cetyl ether, and polyoxyethylene (10) polyoxypropylene (4) cetyl ether; silicone surfactants such as polyoxyethylene-methylpolysiloxane copolymer, lauryl PEG-9 polydimethylsiloxyethyl dimethicone, and PEG-9 polydimethylsiloxyethyl dimethicone;

[0040] Examples of texture improvers include guar gum, locust bean gum, carrageenan, xanthan gum, polyvinylpyrrolidone, polyethylene glycol, bentonite, alginic acid, macrogol, and cellulose-based texture improvers (methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, hydroxymethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, carboxymethyl cellulose, carboxyethyl cellulose, etc.).

[0041] Examples of chelating agents include ethylenediaminetetraacetic acid (edetic acid), ethylenediaminetetraacetate (sodium salt (sodium edetate: Japanese Pharmacopoeia, EDTA-2Na, etc.), potassium salt, etc.), phytic acid, gluconic acid, polyphosphoric acid, metaphosphoric acid, etc. Among these, sodium edetate is preferred.

[0042] Examples of preservatives or antiseptics include benzoic acid, sodium benzoate, dehydroacetic acid, sodium dehydroacetate, isobutyl paraoxybenzoate, isopropyl paraoxybenzoate, butyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, methyl paraoxybenzoate, phenoxyethanol, thymol, isopropylmethylphenol, sorbic acid, potassium sorbate, chlorhexidine gluconate, methylisothiazoline, iodopropynyl butylcarbamate, 1,3-propanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, and sodium pyrosulfite.

[0043] Active ingredient The topical composition of the present embodiment can contain various active ingredients (medicinal active ingredients, cosmetic active ingredients, etc.) Examples of the active ingredients include anti-inflammatory agents, antihistamines, antibacterial ingredients, antifungal agents, local anesthetics, antipruritic agents other than antihistamines, moisturizers, cooling agents, ultraviolet absorbing agents or ultraviolet scattering agents, vitamins, and astringent ingredients. One or more active ingredients may be used as long as the effects of the present invention are not impaired.

[0044] The anti-inflammatory agent may be either a non-steroidal or a steroidal one. Examples of non-steroidal anti-inflammatory agents include allantoin, glycyrrhizic acid, glycyrrhetinic acid, acetaminophen, epsilon-aminocaproic acid, berberine, azulene, zinc; plant extracts such as licorice extract, sage extract, and rosemary extract; fenamic acid anti-inflammatory agents such as flufenamic acid and tolfenamic acid; arylacetic acid anti-inflammatory agents such as acemetacin, indomethacin, and diclofenac; propionic acid anti-inflammatory agents such as aminoprofen, ibuprofen, ketoprofen, ibuprofen piconol, pranoprofen, and loxoprofen; oxicam anti-inflammatory agents such as piroxicam and meloxicam; methyl salicylate, glycol salicylate, and salts thereof.

[0045] The salt may be any pharma- ceutically or physiologically acceptable salt, and examples of the salt include inorganic acid salts and organic acid salts. Examples of inorganic acid salts include hydrochloride, hydrobromide, nitrate, sulfate, phosphate, etc. Examples of organic acid salts include monocarboxylates such as acetate, trifluoroacetate, butyrate, palmitate, and stearate, polycarboxylates such as fumarate, maleate, succinate, and malonate, oxycarboxylates such as lactate, tartrate, and citrate, and organic sulfonates such as methanesulfonate, toluenesulfonate, tosylate, and napadisilate. Other examples include salts with organic bases (organic amine salts such as methylamine salts, triethylamine salts, triethanolamine salts, morpholine salts, piperazine salts, pyrrolidine salts, tripyridine salts, and picoline salts), and salts with inorganic bases (ammonium salts; alkali metal salts such as sodium salts and potassium salts, alkaline earth metal salts such as calcium salts and magnesium salts, and metal salts such as zinc salts and aluminum salts).

[0046] Examples of non-steroidal anti-inflammatory agents that are salts include dipotassium glycyrrhizinate, monoammonium glycyrrhizinate, stearyl glycyrrhizinate, stearyl glycyrrhetinate, indomethacin hydrochloride, diclofenac sodium salt, berberine sulfate, berberine hydrochloride, azulene sulfonate sodium salt, zinc sulfate, zinc lactate, loxoprofen sodium salt, and butyl flufenamate (ufenamate).

[0047] The steroidal anti-inflammatory agents include steroid compounds such as prednisolone, hydrocortisone, cortisone, dexamethasone, and derivatives thereof.

[0048] Representative examples of the derivatives include esters (particularly esters with organic or inorganic acids), salts, and salts of esters. Examples of the ester include esters with organic acids such as valeric acid, acetic acid, succinic acid, butyric acid (butanoic acid), propionic acid, and salicylic acid; and esters with inorganic acids such as phosphoric acid. In addition, one molecule may contain a plurality of esters. When one molecule contains a plurality of esters, it may contain a plurality of esters with one kind of acid, or it may contain esters with two or more kinds of acids. Examples of the salt include salts with organic bases (organic amine salts such as methylamine salt, triethylamine salt, triethanolamine salt, morpholine salt, piperazine salt, pyrrolidine salt, tripyridine salt, and picoline salt), and salts with inorganic bases (ammonium salt; alkali metal salts such as sodium salt and potassium salt, alkaline earth metal salts such as calcium salt and magnesium salt, and metal salts such as zinc salt and aluminum salt).

[0049] Specific examples of derivatives of steroid compounds include hydrocortisone esters such as cortisone acetate, prednisolone valerate acetate (PVA), prednisolone acetate, dexamethasone acetate, hydrocortisone butyrate (particularly hydrocortisone-17-butyrate), hydrocortisone acetate, and betamethasone valerate.

[0050] The concentration of the anti-inflammatory agent can be, relative to the total amount of the composition, 0.0125% by mass or more, 0.025% by mass or more, 0.05% by mass or more, 0.1% by mass or more, 0.125% by mass or more, 0.2% by mass or more, or 0.5% by mass or more, and can be 6% by mass or less, 5% by mass or less, 2% by mass or less, 1% by mass or less, 0.5% by mass or less, 0.25% by mass or less, or 0.125% by mass or less. The concentration of the nonsteroidal anti-inflammatory agent can be 0.1% by mass or more, 0.2% by mass or more, or 0.5% by mass or more, and can be 6% by mass or less, 5% by mass or less, 2% by mass or less, or 1% by mass or less, based on the total amount of the composition. The concentration of the steroidal anti-inflammatory agent may be, relative to the total amount of the composition, 0.0125% by mass or more, 0.025% by mass or more, 0.05% by mass or more, or 0.125% by mass or more, and may be 6% by mass or less, 5% by mass or less, 2% by mass or less, 0.5% by mass or less, 0.25% by mass or less, or 0.125% by mass or less.

[0051] Examples of antihistamines include ethanolamine antihistamines such as diphenhydramine and diphenylpyraline, propylamine antihistamines such as chlorpheniramine, phenothiazine antihistamines such as mequitazine and promethazine, piperazine antihistamines such as cetirizine and meclizine, ketotifen, olopatadine, fexofenadine, epinastine, azelastine, and salts thereof. Examples of the salt include salts with organic acids, salts with inorganic acids, salts with organic bases, and salts with inorganic bases, which are exemplified for the anti-inflammatory agent. Specific examples include diphenhydramine hydrochloride, diphenhydramine salicylate, diphenylpyraline hydrochloride, chlorpheniramine maleate, promethazine hydrochloride, cetirizine hydrochloride, meclizine hydrochloride, ketotifen fumarate, olopatadine hydrochloride, fexofenadine hydrochloride, epinastine hydrochloride, and azelastine hydrochloride.

[0052] The concentration of the antihistamine can be 0.1% by weight or more, 0.15% by weight or more, or 0.2% by weight or more, and can be 2% by weight or less, 1% by weight or less, or 0.5% by weight or less, based on the total weight of the composition.

[0053] Examples of antibacterial components include benzoyl peroxide, adapalene, phenolic disinfectants (isopropylmethylphenol, triclosan, phenoxyethanol, etc.), iodine disinfectants (povidone iodine, polyvinyl alcohol iodine, cyclodextrin iodine, etc.), chlorine disinfectants (hypochlorous acid, sodium hypochlorite, calcium hypochlorite, chlorinated isocyanuric acid, etc.), alkyl quaternary ammonium salt disinfectants (cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, dequalinium chloride, etc.), biguanide disinfectants (chlorhexidine hydrochloride, chlorhexidine gluconate, etc.), alkyldiaminoethylglycine hydrochloride, sodium benzoate, ethanol, chlorobutanol, salicylic acid, cresol, etc.

[0054] The concentration of the antibacterial component can be 0.01% by weight or more, 0.03% by weight or more, or 0.05% by weight or more, and can be 0.5% by weight or less, 0.3% by weight or less, or 0.1% by weight or less, based on the total weight of the composition.

[0055] Examples of antifungal agents include azole antifungal agents such as lanoconazole, miconazole, miconazole and its salts (such as miconazole nitrate), efinaconazole, luliconazole, tioconazole, isoconazole, isoconazole and its salts (such as isoconazole nitrate), clotrimazole, bifonazole, oxiconazole and its salts (such as oxiconazole nitrate), and econazole and its salts (such as econazole nitrate); allylamine antifungal agents such as terbinafine hydrochloride; benzylamine antifungal agents such as butenafine hydrochloride; and morpholine antifungal agents such as amorolfine hydrochloride.

[0056] The concentration of the antifungal agent can be 0.05% by mass or more, 0.1% by mass or more, or 0.5% by mass or more, and can be 5% by mass or less, 3% by mass or less, or 1% by mass or less, based on the total amount of the composition.

[0057] Examples of local anesthetics include lidocaine, dibucaine, mepivacaine, procaine, meprylcaine, ethyl aminobenzoate, and oxypolyethoxydodecane.

[0058] Examples of the salt include salts with organic acids, salts with inorganic acids, salts with organic bases, and salts with inorganic bases, which are exemplified for the anti-inflammatory agent. Specific examples include lidocaine hydrochloride, dibucaine hydrochloride, mepivacaine hydrochloride, procaine hydrochloride, meprylcaine hydrochloride, etc.

[0059] The concentration of the local anesthetic may be 0.05% by weight or more, 0.2% by weight or more, or 0.5% by weight or more, and may be 5% by weight or less, 3% by weight or less, or 2% by weight or less, based on the total weight of the composition.

[0060] Examples of antipruritic agents other than antihistamines include crotamiton.

[0061] The concentration of the antipruritic agent other than the antihistamine can be 1% by mass or more, 2% by mass or more, or 4% by mass or more, and can be 10% by mass or less, 8% by mass or less, or 6% by mass or less, based on the total amount of the composition.

[0062] Examples of moisturizing ingredients include heparinoids, sodium chondroitin sulfate, and urea.

[0063] The concentration of the moisturizing component can be, relative to the total amount of the composition, 0.1% by mass or more, 0.2% by mass or more, 1% by mass or more, 5% by mass or more, or 15% by mass or more, and can be 20% by mass or less, 10% by mass or less, 1% by mass or less, or 0.3% by mass or less.

[0064] Examples of ultraviolet absorbers or ultraviolet scattering agents include 2-ethylhexyl paramethoxycinnamate, 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoic acid hexyl ester, 2,4,6-tris[4-(2-ethylhexyloxycarbonyl)anilino]-1,3,5-triazine, t-butylmethoxydibenzoylmethane, ethylhexyl dibenzylidene dioxoimidazolidinepropionate, ethylhexyl triazone, paraaminobenzoic acid and derivatives thereof, octyl paradimethylaminobenzoate, ethylene glycol salicylate, dihydroxybenzophenone, titanium oxide, and zinc oxide.

[0065] Examples of cooling agents include terpenoids and essential oils. Examples of terpenoids include menthol, anethole, eugenol, camphor, geraniol, cineol, borneol, limonene, and ryuno, etc. These may be in the d-, l-, or dl-form. Examples of essential oils include peppermint oil, cool mint oil, spearmint oil, peppermint oil, fennel oil, cinnamon oil, bergamot oil, eucalyptus oil, rose oil, and lavender oil.

[0066] The concentration of the cooling agent may be 0.1% by mass or more, 0.5% by mass or more, or 1% by mass or more, and may be 15% by mass or less, 12.3% by mass or less, 10% by mass or less, 5% by mass or less, or 2% by mass or less, based on the total amount of the composition.

[0067] Examples of vitamins include vitamin A oil, retinol palmitate, tocopherol, tocopherol acetate, tocopherol succinate, tocopherol calcium succinate, ubiquinone derivatives and salts thereof, riboflavin, flavin mononucleotide, flavin adenine dinucleotide, riboflavin butyrate, riboflavin tetrabutyrate, ascorbic acid, sodium ascorbate, sodium ascorbyl phosphate, magnesium ascorbyl phosphate, ascorbyl palmitate, pyridoxine hydrochloride, pyridoxamine hydrochloride, cyanocobalamin, folic acid, nicotinic acid, nicotinamide, pantothenic acid, calcium pantothenate, pantothenyl alcohol (panthenol), pantothenyl ethyl ether and other pantothenic acids, biotin, and γ-oryzanol.

[0068] The concentration of the vitamins can be 0.001% by mass or more, 0.01% by mass or more, or 0.1% by mass or more, and can be 5% by mass or less, 2% by mass or less, or 1% by mass or less, relative to the total amount of the composition.

[0069] Examples of astringent ingredients include zinc p-phenolsulfonate and zinc oxide.

[0070] Formulation The formulation of the topical composition of this embodiment may be in the form of a cream, an ointment (oil-soluble ointment, water-soluble ointment), a gel, a liniment, etc. Among these, an oil-soluble ointment is preferred in that it exhibits the effects of the present invention more remarkably. In the case of an emulsion composition such as an emulsion or cream, it may be of either the oil-in-water type or the water-in-oil type, but the water-in-oil type is preferred in that the effects of the present invention are more pronounced.

[0071] container Examples of materials for the container that holds the topical composition of this embodiment include containers in which some or all, preferably all, of the surface that comes into contact with the topical composition is made of at least one material selected from the group consisting of polyolefin resin, acrylic resin, polyester, polycarbonate, fluororesin, polyvinyl chloride, polyamide, ABS resin, AS resin, polyacetal, modified polyphenylene ether, polyarylate, polysulfone, polyimide, cellulose acetate, aluminum, and glass.

[0072] From the viewpoint of ease of handling the preparation and ease of molding, preferred materials for the container include aluminum, polyethylene (PE) (including high density polyethylene (HDPE), low density polyethylene (LDPE), very low density polyethylene, linear low density polyethylene (LLDPE), ultra-high molecular weight polyethylene, etc.), polypropylene (PP) (including isotactic polypropylene, syndiotactic polypropylene, atactic polypropylene, etc.), ethylene-propylene copolymer, polyolefin resins such as polymethylpentene, polybutene-1, 1,2-polybutadiene, etc., and polyester resins such as polyethylene terephthalate (PET), polybutylene terephthalate, polyethylene naphthalate, etc., and more preferred are polyethylene, polypropylene, and polyethylene terephthalate. The material of the innermost layer of the container is preferably polyethylene (PE) (high density polyethylene (HDPE), low density polyethylene (LDPE), very low density polyethylene, linear low density polyethylene (LLDPE), polypropylene, or aluminum.

[0073] When the container has a lid or cap, the material of the lid or cap can be the same as those exemplified as the container material above. Examples of containers for storing the composition include containers with nozzles, containers with pumps, jar containers, tube containers, containers with holes in the inner plugs, containers with hinge caps, sponge head containers, roll-on containers, and the like.

[0074] Usage and dosage The topical composition of this embodiment may be a pharmaceutical composition, a cosmetic composition, a quasi-drug composition, or the like. The topical composition of the present embodiment can be applied to the skin (body skin, scalp, etc.), mucous membranes (oral mucosa, anal mucosa, vaginal mucosa, etc.), nails, etc. Among them, a skin topical composition is preferable, and a facial topical composition is more preferable. The topical composition of the present embodiment can be one that is not for oral use or hair use. An appropriate amount of the topical composition of this embodiment can be applied (coated) to the affected area, for example, 1 to 5 times, 1 to 3 times, 1 to 2 times, or once.

[0075] Purpose The topical composition of this embodiment can be used as a pharmaceutical or quasi-drug, particularly as an external preparation, with one or more therapeutic effects such as anti-inflammatory, antibacterial, and antipruritic, depending on the active ingredient optionally blended. For example, the topical composition of this embodiment can be suitably used as an external composition with efficacy and effect of itching, dry skin accompanied by itching, rash, hives, eczema, insect bites, lumps and tightness of the skin after a wound or burn (excluding the face), acne, keratosis, cracks and chapped skin, dry skin, dermatitis, rough skin, chilblains (excluding sores), swelling, muscle pain, joint pain after a bruise or sprain, athlete's foot, jock itch, ringworm, heat rash, sores, and disinfection of wounds. In addition, the topical composition of this embodiment can be used to prevent dry skin by supplementing or maintaining oil content in the skin (including the scalp), protecting the skin, or maintaining the flexibility of the skin. In addition, the topical composition of this embodiment can be used as a cosmetic or quasi-drug, particularly as an external preparation thereof, one of the purposes of which is to prevent dryness or moisturize the skin (including the scalp).

[0076] The topical composition of this embodiment may not contain 0.5 to 2 mass % of an anionic surfactant selected from fatty acid soaps, alkyl sulfate surfactants, and glutamate surfactants, relative to the total amount of the composition.

[0077] Method for preparing a topical composition The topical composition of the present embodiment can be prepared by mixing silicon dioxide, polyacrylic acid or its derivative, and petrolatum together with other components that are blended as necessary. The petrolatum can be heated and dissolved in advance. In addition, when a solid oil other than petrolatum (especially a non-polar solid oil other than petrolatum) is included, the petrolatum and the other solid oil can be heated and dissolved and mixed. The carboxyvinyl polymer may be mixed with a mixture of petrolatum or a solid oil containing petrolatum, which has been heated and dissolved, and then mixed with the other components, or, if a liquid non-polar oil is contained, the carboxyvinyl polymer may be mixed with the liquid non-polar oil and then mixed with the other components. When the silicon dioxide contains a liquid polar oil, it may be mixed with the liquid polar oil and then mixed with other components. When an active ingredient is included, depending on the polarity of the active ingredient, the active ingredient may be dissolved in water or an aqueous base and then mixed with other ingredients, or the active ingredient may be mixed with a mixture of petrolatum or a solid oil containing petrolatum dissolved by heating, a liquid nonpolar oil, or a liquid polar oil, and then mixed with other ingredients. EXAMPLES

[0078] The present embodiment will be described in more detail below with reference to examples, but the present invention is not limited to these.

[0079] (1) Preparation of topical composition A topical composition was prepared by a conventional method according to the formulation in Table 1. That is, phase (a) containing petrolatum and solid oil was heated, dissolved and mixed, phase (b) containing a mixture of liquid non-polar oil liquid paraffin and carboxyvinyl polymer was added and mixed, and then phase (c) containing a mixture of liquid polar oil and light anhydrous silicic acid was added and mixed to obtain a topical composition in the form of an ointment.

[0080] (2) Sensory evaluation The obtained compositions for external use were filled into plastic tubes, and the feeling of use was evaluated by the VAS (Visual Analog Scale) method. That is, six expert panelists applied 0.2 g of each composition for external use to an area of ​​5 cm square on the arm indoors, and wrote down the answer value for each evaluation item shown in Table 1 on a 10 cm straight line marked with 0 (left end) and 100 (right end). The formulation of each composition was not known to the panelists.

[0081] The evaluation items and evaluation criteria for the VAS evaluation are as follows: Shine immediately after application: The shine caused by the topical composition on the skin surface immediately after application was evaluated, with 0 (far left) representing "not felt at all" and 100 (far right) representing "very strong feeling." Adhesion immediately after application: The strength of absorption into the skin immediately after application was evaluated, with 0 (far left) representing "not felt at all" and 100 (far right) representing "very strong feeling." Coat feel immediately after application: The sensation of being covered immediately after application was evaluated, with 0 (far left) representing "no sensation at all" and 100 (far right) representing "a very strong sensation." Stickiness during application: The stickiness of the topical composition felt by the fingers during application was evaluated, with 0 (far left) representing "not sticky at all" and 100 (far right) representing "very sticky." Stickiness immediately after application: The stickiness of the topical composition on the skin surface immediately after application was evaluated, with 0 (far left) representing "not sticky at all" and 100 (far right) representing "very sticky."

[0082] Table 1 shows the VAS assessment items and the average response values. [Table 1] Each of the compositions for external use in Examples 1 to 7 contains 5 to 11.5% by mass of petrolatum, and thus provides a sufficient emollient effect. As shown in Table 1, the compositions have good adhesion to the skin.

[0083] Comparative Example 1 does not contain the carboxyvinyl polymer in Example 1, and has the same composition as Example 1 except that it has a higher content of liquid paraffin, which is the same liquid nonpolar oil in the (B) phase. Comparative Example 2 does not contain the light anhydrous silicic acid in Example 1, and has the same composition as Example 1 except that it has a higher content of medium-chain fatty acid triglyceride and diethyl sebacate, which are the same liquid polar oil in the (C) phase.

[0084] Comparing Example 1 with Comparative Example 1, it can be seen that the incorporation of carboxyvinyl polymer reduced the shine on the skin immediately after application.Comparing Example 1 with Comparative Example 2, it can be seen that the incorporation of light anhydrous silicic acid reduced the shine on the skin immediately after application.

[0085] Comparing Example 1 with Comparative Example 1, it can be seen that the incorporation of carboxyvinyl polymer improved the adhesion to the skin and the coated feeling on the skin after application.Comparing Example 1 with Comparative Example 2, it can be seen that the incorporation of light anhydrous silicic acid improved the adhesion to the skin and the coated feeling on the skin after application.

[0086] Comparing Example 1 and Comparative Example 1, it can be seen that the incorporation of carboxyvinyl polymer reduces stickiness during application and stickiness on the skin after application. Since carboxyvinyl polymer is a component that usually disperses in a composition containing a large amount of water and exerts a thickening effect, it is expected that the incorporation of carboxyvinyl polymer increases stickiness, but in the external composition of this embodiment, it is considered that the carboxyvinyl polymer reduces stickiness by combining with petrolatum and silicon dioxide.

[0087] From the above, it can be seen that by containing carboxyvinyl polymer, silicon dioxide, and petrolatum, the shine of the skin immediately after application is suppressed, the formulation adheres closely to the skin immediately after application and feels coated immediately after application, and stickiness during the application process and immediately after application is suppressed.

[0088] Formulation examples of the topical composition of the present invention are shown below. All formulation examples are in units of % by mass. Formulation example 1: Ointment (filled in an aluminum tube) Prednisolone valerate acetate 0.15% White petrolatum 11.5% Carboxyvinyl polymer 4% Light anhydrous silicic acid 6% Medium Chain Triglycerides 30% Diethyl sebacate 15% Polyethylene powder 1.5% Microcrystalline wax 4.5% Paraffin 2% Ceresin 5.5% Liquid paraffin remaining Total 100g

[0089] Formulation example 2: Ointment (filled in a PET, PP, or PE tube) Diphenhydramine 1% White Vaseline 24% Carboxyvinyl polymer 3% Light anhydrous silicic acid 4.5% Medium Chain Triglycerides 20% Isopropyl myristate 15% Polyethylene powder 1% Microcrystalline wax 10% Paraffin 2% White beeswax 4% Light liquid paraffin remaining Total 100g

[0090] Formulation example 3: Ointment (filled in a PP jar) Ufenamart 5% White petrolatum 17.5% Carboxyvinyl polymer 5% Light anhydrous silicic acid 8% Medium Chain Triglycerides 15% Octyldodecanol 15% Polyethylene powder 1.5% Microcrystalline wax 5% Paraffin 2% White beeswax 6% Squalane remaining Total 100g

[0091] The following additional notes are provided with respect to some or all of the above-described embodiments, but the present invention is not limited to the following notes. [Appendix 1] A topical composition comprising (A) silicon dioxide, (B) polyacrylic acid or a derivative thereof, and (C) petrolatum. [Appendix 2] The topical composition described in Appendix 1, further comprising (D) a solid oil other than petrolatum. [Appendix 3] The topical composition described in Appendix 1 or 2, further comprising (E) a liquid polar oil. [Appendix 4] The composition for external use according to any one of claims 1 to 3, further comprising (F) a liquid non-polar oil. [Appendix 5] 5. The composition for external use according to any one of claims 1 to 4, wherein the water content is 10% by mass or less based on the total amount of the composition. [Appendix 6] 6. The composition for external use according to any one of claims 1 to 5, which is a composition for external use on the skin. [Industrial Applicability]

[0092] The topical composition of this embodiment has high commercial value because it contains petrolatum to an extent that it has sufficient moisturizing properties and adhesion to the skin, yet prevents the skin from becoming shiny or sticky.

Claims

1. A topical composition comprising (A) silicon dioxide, (B) polyacrylic acid or a derivative thereof, and (C) petrolatum.

2. The composition for external use according to claim 1 , further comprising (D) a solid oil other than petrolatum.

3. The composition for external use according to claim 1 or 2, further comprising (E) a liquid polar oil.

4. The topical composition according to claim 1 or 2, further comprising (F) a liquid non-polar oil.

5. The composition for external use according to claim 1 or 2, wherein the water content is 10% by mass or less based on the total amount of the composition.

6. The composition for external use according to claim 1 or 2, which is a composition for external use on the skin.

Citation Information

Patent Citations

  • Adhesive composition for dentures comprises an adhesive, a thickener having a carbomer, a paraffin-containing substance and a highly dispersed filler

    DE102005031771A1

  • Torpent and external preparation for skin

    JP2006257012A

  • Cosmetic containing new malic acid ester

    JP2020002056A

  • Improved denture adhesives

    JP2020512326A

  • Topical Compositions Comprising Myrica Gale Oil

    US20080069898A1